| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021115026 |
| P356 | DOI | 10.1186/2050-6511-14-10 |
| P932 | PMC publication ID | 3575309 |
| P698 | PubMed publication ID | 23391323 |
| P2093 | author name string | Maria Gustafsson | |
| Hugo Lövheim | |||
| Stig Karlsson | |||
| P2860 | cites work | Comparison of behavioral and psychological symptoms of dementia and psychotropic drug treatments among old people in geriatric care in 2000 and 2007 | Q84916981 |
| The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study | Q44815098 | ||
| Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). | Q44944678 | ||
| Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS). | Q46729093 | ||
| Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics | Q46733669 | ||
| Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis | Q46868339 | ||
| Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study | Q48749105 | ||
| Behavioral and psychological symptoms of dementia in relation to level of cognitive impairment. | Q51891838 | ||
| Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. | Q51914146 | ||
| A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. | Q52064856 | ||
| The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. | Q54088275 | ||
| Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia | Q57491167 | ||
| Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group | Q73031772 | ||
| A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia | Q81228549 | ||
| Effects of a restraint minimization program on staff knowledge, attitudes, and practice: a cluster randomized trial | Q82734036 | ||
| Behavioral and psychological symptoms of dementia | Q21129432 | ||
| “Mini-mental state” | Q25938989 | ||
| Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. | Q30374315 | ||
| Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia | Q33536593 | ||
| Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease | Q33980960 | ||
| Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients | Q34116373 | ||
| Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. | Q34497247 | ||
| Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence | Q34554740 | ||
| Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. | Q34573456 | ||
| Antipsychotic drug use and mortality in older adults with dementia | Q34580030 | ||
| Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials | Q34651137 | ||
| Antipsychotic prescribing in older people | Q35212983 | ||
| Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism | Q35819407 | ||
| Adverse effects of atypical antipsychotics in the elderly: a review | Q36677274 | ||
| Conventional and atypical antipsychotics in the elderly : a review. | Q36834289 | ||
| Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD) | Q37420475 | ||
| Management of behavioral problems in Alzheimer's disease | Q37680018 | ||
| Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. | Q41472935 | ||
| Long-term care of the elderly. A descriptive study of 3600 institutionalized patients in the county of Västerbotten, Sweden | Q41888739 | ||
| Risperidone in the treatment of behavioral disorders in elderly patients with dementia | Q43657105 | ||
| Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease | Q44060139 | ||
| A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. | Q44359598 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 10 | |
| P577 | publication date | 2013-02-08 | |
| P1433 | published in | BMC pharmacology & toxicology | Q27724429 |
| P1476 | title | Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units | |
| P478 | volume | 14 |
| Q36091476 | A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice |
| Q39684580 | Antipsychotic drug use and associations with neuropsychiatric symptoms in persons with impaired cognition: a cross-sectional study |
| Q37196381 | Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses |
| Q44324076 | Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings |
| Q60915517 | Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients |
| Q98181083 | Drug related problems in older adults living with dementia |
| Q39632952 | Drug-related hospital admissions among old people with dementia. |
| Q47737322 | Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms |
| Q35631283 | Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia. |
| Q47763408 | Factors associated with appropriate psychotropic drug prescription in nursing home patients with severe dementia |
| Q92888046 | Implementing a multidisciplinary psychotropic medication review among nursing home residents with dementia: a process evaluation |
| Q90012974 | Mikania Micrantha Improved Memory Perform on Dementia Model |
| Q88251508 | Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study |
| Q35044533 | PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol |
| Q36279048 | Persistent use of psychotropic drugs in nursing home residents in Norway |
| Q33841837 | Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial |
| Q53626464 | Pharmacological and non-pharmacological treatment preferences of healthcare professionals and proxies for challenging behaviors in patients with dementia. |
| Q88631478 | Polimedication: applicability of a computer tool to reduce polypharmacy in nursing homes |
| Q64087477 | Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline |
| Q92857797 | Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project |
| Q38429094 | Psychoactive prescribing for older people--what difference does 15 years make? |
| Q38911610 | Psychotropic drug prescriptions in Western European nursing homes. |
| Q35033086 | Psychotropic drug use among people with dementia--a six-month follow-up study |
| Q33729950 | Psychotropic drug use and mortality in old people with dementia: investigating sex differences |
| Q34681144 | Quetiapine Misuse and Abuse: Is it an Atypical Paradigm of Drug Seeking Behavior? |
| Q90669546 | Reducing inappropriate psychotropic drug use in nursing home residents with dementia: protocol for participatory action research in a stepped-wedge cluster randomized trial |
| Q87422997 | The effects of public reporting on physical restraints and antipsychotic use in nursing home residents with severe cognitive impairment |
| Q40099193 | The use of antipsychotics among people treated with medications for dementia in residential aged care facilities |
| Q33910629 | Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish context |
| Q41491367 | Use of Antipsychotic Drugs by Elderly Primary Care Patients and the Effects of Medication Reviews: A Cross-Sectional Study in Sweden. |
| Q38282634 | Use of the Screening Tool of Older Persons' Prescriptions (STOPP) and the Screening Tool to Alert doctors to the Right Treatment (START) in hospitalised older people. |
| Q91648139 | Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: Insights from the HALT study |
Search more.